Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-11
2006-07-11
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S328000
Reexamination Certificate
active
07074822
ABSTRACT:
Substituted β-lactones (oxetanones) corresponding to the formula I,wherein R1, R2and n have the meanings given in the specification, and pharmaceutical compositions which contain these compounds and have a pancreatic lipase-inhibiting action, as well as a process for the preparation of the compounds of Formula I and intermediate products of this process.
REFERENCES:
patent: 4175186 (1979-11-01), Rasheed et al.
patent: 4189438 (1980-02-01), Umezawa et al.
patent: 4358602 (1982-11-01), Umezawa et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4806564 (1989-02-01), Chabala et al.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 5245056 (1993-09-01), Karpf et al.
patent: 5376674 (1994-12-01), Derungs et al.
patent: 5399720 (1995-03-01), Karpf et al.
patent: 5466708 (1995-11-01), Derungs et al.
patent: 5986132 (1999-11-01), Reeve et al.
patent: 6235305 (2001-05-01), Mullins
patent: 6342519 (2002-01-01), Mullins
patent: 6348492 (2002-02-01), Mullins
patent: 2001/0012852 (2001-08-01), Mullins
patent: 2002/0016307 (2002-02-01), Mullins
patent: 2002/0045767 (2002-04-01), Mullins
patent: 2003/0162961 (2003-08-01), Coates et al.
patent: 2003/0181433 (2003-09-01), Schoenafinger et al.
patent: 31 09 335 (1982-03-01), None
patent: 0 129 748 (1985-01-01), None
patent: 0 293 132 (1988-11-01), None
patent: 0 443 449 (1991-08-01), None
patent: 0 444 428 (1991-09-01), None
patent: 0 444 482 (1991-09-01), None
patent: 3-115274 (1991-05-01), None
patent: WO 97/19050 (1997-05-01), None
patent: WO 01/32669 (2001-05-01), None
patent: WO 01/32670 (2001-05-01), None
patent: WO 03/050154 (2003-06-01), None
patent: WO 03/072555 (2003-09-01), None
patent: WO 2004/065346 (2004-08-01), None
Silvia Cardani, et al., “Titanium Tetrachloride-Mediated Enantioselective Synthesis of Trans β-Lactones”, Tetrahedron, 1992, pp. 5557-5564, vol. 48, No. 27, Pergamon Press Ltd. Printed in Great Britain, XP-002330603.
Scott G. Nelson, et al., “Catalytic Asymmetric Acyl Halide-Aldehyde Cyclocondensation Reactions of Substituted Ketenes”, J. AM. Chem. Soc., 2004, pp. 14-15, vol. 126, American Chemical Society, XP-00230604.
Keith T. Mead, et al., “A New Approach to the Preparation of 2-Substituted Tetrahydrofurans with Alpha-Syn Selectivity”, Tetrahedron Letters, 1989, pp. 6829-6832, vol. 30, No. 49, Pergamon Press Plc, XP-002330605.
Cunxing Zhao, et al., “A β-Lactone-Based Route to Cyclopentanes via Intramolecular Allyisilane Additions. An Unexpected Friedel-Crafts Allkylation.” Tetrahedron Letters, 1997, pp. 6537-6540, vol. 38, No. 37, Elsevier Science Ltd., PII: S0040-4039(97)01529-3.
Hong Woon Yang, et al., “Studies of the Tandem Mukalyama Aldol-Lactonization (TMAL) Reaction: A Concise and Highly Diastereoselective Route to β-Lactones Applied to the Total Synthesis of the Potent Pancreatic Lipase Inhibitor, (-) Panclicin D”, Tetrahedron, 1997, pp. 16471-16488, vol. 53, No. 48, Elsevier Science Ltd., PII: S0040-4020(97)01029-6.
Makoto Oba, et al., “Radical-Based Deoxygenation of Aliphatic Alcohols via Thioxocarbamate Derivatives”, Tetrahedron, 1994, pp. 10193-10200, vol. 50, No. 34, Elsevier Science Ltd., 0040-4020(94)00596-6.
Eugen J. Verspohl, “ Adipositas-Behandlung Beim Typ-2-Diabetiker”.
Masahiko Nishiyama, et al. “Addition Reaction and Deoxygenation of Alcohols Using Osothiocyanates and Triethyisilane-DTBP”, Tetrahedron Letters, 1993, pp. 3745-3748, vol. 34, No. 23, Pergamon Press Ltd.
Agnes Pommier, et al., “Recent Advances in β-Lactone Chemistry”, Synthesis, 1993, pp. 441-459.
Derek H. R. Barton, et al., “The Invention of Radical Reactions. 32. Radical Deoxygenations, Dehalogenations, and Deaminations with Dialkyl Phosphites and Hypophosphorous Acid as Hydrogen Sources”, J. Org. Chem., 1993, pp. 6838-6842, vol. 58, American Chemical Society.
Antel Jochen
Eyting Sabine
Gregory Peter Colin
Waldeck Harald
Wolff Maike
Crowell & Moring LLP
Dentz Bernard
Solvay Pharmaceuticals GmbH
LandOfFree
Alkyl carbamate-substituted β-lactones, process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl carbamate-substituted β-lactones, process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl carbamate-substituted β-lactones, process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3577118